Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
Authors
Keywords
Glioblastoma, Bevacizumab, Metabolism, Adaptation
Journal
ACTA NEUROPATHOLOGICA
Volume 129, Issue 1, Pages 115-131
Publisher
Springer Nature
Online
2014-10-16
DOI
10.1007/s00401-014-1352-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma
- (2015) John de Groot et al. Oncotarget
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells
- (2013) Annegret Kathagen et al. ACTA NEUROPATHOLOGICA
- Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes
- (2013) Daniel Stieber et al. ACTA NEUROPATHOLOGICA
- Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
- (2013) Anna Golebiewska et al. BRAIN
- Molecular analysis of a recurrent glioblastoma treated with bevacizumab
- (2013) Takuya Furuta et al. Brain Tumor Pathology
- 1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond
- (2013) A. Jahangiri et al. CANCER RESEARCH
- Acidity Generated by the Tumor Microenvironment Drives Local Invasion
- (2013) V. Estrella et al. CANCER RESEARCH
- 1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma
- (2013) W. S. Carbonell et al. CANCER RESEARCH
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition
- (2013) Y. Piao et al. CLINICAL CANCER RESEARCH
- Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
- (2013) Krishan Kumar et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
- (2013) Yasushi Soda et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Multivoxel 1H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting
- (2013) Bob Hamans et al. NEURO-ONCOLOGY
- Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival
- (2013) E. Hattingen et al. NEURO-ONCOLOGY
- Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion
- (2013) Deborah Huveldt et al. PLoS One
- Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2
- (2013) Anna C. Navis et al. PLoS One
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM
- (2013) Nikdokht Farid et al. Frontiers in Oncology
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma
- (2012) Y.-L. Hu et al. CANCER RESEARCH
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
- (2012) A. McIntyre et al. CLINICAL CANCER RESEARCH
- Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation
- (2012) Antonello Vidiri et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
- (2012) Y. Piao et al. NEURO-ONCOLOGY
- Metabolism of [U-13C]glucose in human brain tumorsin vivo
- (2012) Elizabeth A. Maher et al. NMR IN BIOMEDICINE
- DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
- (2011) J.-L. Li et al. CANCER RESEARCH
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
- (2011) Anna Golebiewska et al. Cell Stem Cell
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab
- (2011) B. M. Ellingson et al. NEURO-ONCOLOGY
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
- (2011) Olivier Keunen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
- (2011) Paolo E. Porporato et al. Frontiers in Pharmacology
- A reproducible brain tumour model established from human glioblastoma biopsies
- (2010) Jian Wang et al. BMC CANCER
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- Development of HIF-1 inhibitors for cancer therapy
- (2009) Barbara Onnis et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions
- (2008) Simone P. Niclou et al. FASEB JOURNAL
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas
- (2008) A. Li et al. MOLECULAR CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now